ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
3,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
6,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
7,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
8,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
11,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
12,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
14,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
17,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,1,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
20,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
20,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
20,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
20,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
20,5,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,1,Hepatitis toxic,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
21,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
22,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
23,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
24,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
25,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
26,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
27,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
28,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
28,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
29,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
29,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
30,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
30,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
31,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
31,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
31,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
31,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
31,8,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
31,9,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
31,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
31,11,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
31,12,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
31,13,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
31,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
31,15,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
31,16,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
31,17,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
31,18,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
31,19,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,20,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
31,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
32,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
32,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
33,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
33,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
33,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
33,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
33,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
33,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
33,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
33,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
33,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
33,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
33,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
33,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,16,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
33,17,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,18,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
33,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
34,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
